Figure 3. CD90^low CB-MSCs inhibited tumor growth and prolonged mouse survival in ovarian cancer model.

(A) Representative bioluminescent images of CB-MSCs and BM-MSCs treated mice compared to saline treated group. MSCs were administered i.p. at week 0 and week 3 at the number of 3 × 10⁶ and 0.5 × 10⁶. (B) Quantified signal of luciferase-expressing ID8 tumor cells (n = 5). (C) Mice survival curve (n = 5). (D) Mouse survival when MSCs were administered i.p. at week 0 at the number of 3 × 10⁶ and the increased number of 3 × 10⁶ at week 3. (E) The time of onset of ascites in saline control and CB-MSCs applied groups.